(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 4.93%9.66B | 13.67%36.42B | 14.59%27.24B | 17.28%18.22B | 13.83%9.21B | 9.39%32.04B | 8.18%23.77B | 3.02%15.54B | 5.41%8.09B | 10.46%29.29B |
Special items of operating revenue | -3.92%5.22M | ---- | 28.11%19.84M | ---- | 5.77%5.43M | ---- | 4.37%15.48M | ---- | 39.48%5.14M | ---- |
Operating income | 4.92%9.67B | 13.67%36.42B | 14.59%27.26B | 17.28%18.22B | 13.83%9.22B | 9.39%32.04B | 8.18%23.79B | 3.02%15.54B | 5.42%8.1B | 10.46%29.29B |
Cost of sales | ---- | -11.43%-28.58B | ---- | -16.38%-14.22B | ---- | -10.43%-25.64B | ---- | -5.09%-12.22B | ---- | -14.85%-23.22B |
Operating expenses | -1.05%-7.36B | -11.43%-28.58B | -13.27%-21.28B | -16.38%-14.22B | -14.42%-7.28B | -10.43%-25.64B | -10.06%-18.79B | -5.09%-12.22B | -7.14%-6.36B | -14.85%-23.22B |
Gross profit | 19.48%2.31B | 22.65%7.85B | 19.59%5.98B | 20.57%4B | 11.67%1.94B | 5.38%6.4B | 1.64%5B | -3.92%3.32B | -0.45%1.73B | -3.63%6.07B |
Selling expenses | 0.88%-249.3M | -39.04%-1.16B | -35.95%-874.09M | -43.33%-608.96M | -13.71%-251.52M | -0.42%-831.59M | -0.89%-642.95M | 3.07%-424.87M | -3.44%-221.2M | -4.76%-828.13M |
Administrative expenses | -7.71%-284.86M | -11.80%-1.2B | -10.92%-847.09M | -7.47%-523.33M | 5.64%-264.46M | 16.46%-1.07B | 30.94%-763.67M | 21.81%-486.94M | 11.76%-280.27M | 0.43%-1.28B |
Research and development expenses | -10.62%-466.83M | -13.15%-1.57B | -9.52%-1.3B | -5.26%-828.03M | -3.25%-422.02M | -8.98%-1.39B | -14.36%-1.19B | -15.04%-786.64M | -25.64%-408.75M | -3.86%-1.27B |
Profit from asset sales | 170.28%2.47M | ---- | -65.72%3.37M | ---- | -161.25%-3.51M | ---- | 53.15%9.83M | ---- | 110.00%5.73M | ---- |
Revaluation surplus | -18.14%33.58M | ---- | 327.58%81.33M | ---- | 98.54%41.03M | ---- | -58.34%-35.74M | ---- | 186.82%20.66M | ---- |
-Changes in the fair value of other assets | -18.14%33.58M | ---- | 327.58%81.33M | ---- | 98.54%41.03M | ---- | -58.34%-35.74M | ---- | 186.82%20.66M | ---- |
Impairment and provision | -69.64%-43.53M | 137.31%51.23M | 126.62%74.38M | 79.36%-20.43M | 41.85%-25.66M | -730.36%-137.28M | -761.62%-279.43M | -435.23%-98.98M | 20.22%-44.12M | -4,776.99%-16.53M |
-Other impairment is provision | -69.64%-43.53M | 137.31%51.23M | 126.62%74.38M | 79.36%-20.43M | 41.85%-25.66M | -730.36%-137.28M | -761.62%-279.43M | -435.23%-98.98M | 20.22%-44.12M | -4,776.99%-16.53M |
Operating interest expense | 32.84%-2.28M | ---- | -473.77%-10.96M | ---- | -228.74%-3.39M | ---- | 51.77%-1.91M | ---- | -309.48%-1.03M | ---- |
Special items of operating profit | 72.90%175.34M | 34.38%478.91M | -41.48%275.26M | -12.41%334.47M | -17.04%101.41M | 108.62%356.4M | 31.01%470.39M | 257.18%381.87M | -1.45%122.25M | 121.98%170.83M |
Operating profit | 34.92%1.45B | 33.86%4.45B | 31.89%3.26B | 23.75%2.36B | 18.71%1.07B | 17.08%3.33B | 5.04%2.47B | 5.86%1.9B | 0.78%902.94M | 28.11%2.84B |
Financing cost | -35.55%-53.62M | -46.42%-388.6M | -9.61%-91.8M | -22.15%-168.54M | -9.43%-39.56M | -0.65%-265.41M | 51.88%-83.75M | 8.26%-137.98M | 44.05%-36.15M | 12.15%-263.69M |
Share of profits of associates | ---- | 102.90%46.97M | ---- | 37.62%23.32M | ---- | -41.28%23.15M | ---- | -14.95%16.95M | ---- | 228.28%39.42M |
Share of profit from joint venture company | ---- | 16.65%5.89M | ---- | 74.52%452K | ---- | -10.45%5.05M | ---- | -91.28%259K | ---- | -41.36%5.64M |
Special items of earning before tax | -48.34%1.12M | ---- | -185.00%-11.79M | ---- | -60.27%2.18M | ---- | 259.79%13.87M | ---- | 102.60%5.47M | ---- |
Earning before tax | 34.73%1.39B | 33.27%4.12B | 31.41%3.15B | 24.01%2.21B | 18.60%1.03B | 17.79%3.09B | 10.68%2.4B | 6.71%1.78B | 4.59%872.26M | 35.23%2.62B |
Tax | -31.01%-220.73M | -33.46%-616.67M | -37.21%-512.53M | -42.11%-374.65M | -4.37%-168.49M | 16.51%-462.07M | 21.50%-373.54M | 31.36%-263.64M | 29.62%-161.43M | 1.37%-553.45M |
After-tax profit from continuing operations | 35.45%1.17B | 33.24%3.5B | 30.34%2.64B | 20.87%1.84B | 21.84%866.05M | 26.96%2.63B | 19.73%2.03B | 18.08%1.52B | 17.56%710.83M | 50.12%2.07B |
Earning after tax | 35.45%1.17B | 33.24%3.5B | 30.34%2.64B | 20.87%1.84B | 21.84%866.05M | 26.96%2.63B | 19.73%2.03B | 18.08%1.52B | 17.56%710.83M | 50.12%2.07B |
Minority profit | 57.79%130.93M | 123.08%200.26M | 171.79%172.74M | 138.27%129.94M | 185.29%82.98M | -26.47%89.77M | -44.53%63.56M | -35.28%54.54M | -39.83%29.09M | -12.57%122.08M |
Profit attributable to shareholders | 33.08%1.04B | 30.06%3.3B | 25.76%2.47B | 16.50%1.71B | 14.86%783.07M | 30.31%2.54B | 24.40%1.96B | 21.82%1.46B | 22.55%681.75M | 57.19%1.95B |
Basic earnings per share | 31.84%0.588 | 28.78%1.8722 | 24.44%1.4 | 15.48%0.97 | 14.36%0.446 | 29.32%1.4538 | 24.31%1.125 | 21.74%0.84 | 21.50%0.39 | 57.19%1.1242 |
Diluted earnings per share | 32.05%0.585 | 28.74%1.8609 | 24.51%1.397 | 15.48%0.97 | 14.18%0.443 | 29.18%1.4455 | 23.98%1.122 | 21.74%0.84 | 21.25%0.388 | 56.61%1.119 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data